Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) reports Q4 and FY2022 financial results

Canopy Growth Corporation (WEED) has released its financial results for the fourth quarter and fiscal year ended March 31, 2022.

" Canopy Growth (TSX:WEED) kicks off summer long weekends with new product line-up

Canopy Growth Corp. has unveiled a line-up of new offerings across its premium brand portfolio.
Canopy Growth - CEO, David Klein

" Canopy Growth (TSX:WEED) divests pharmaceutical C3 cannabinoid compound company

Canopy Growth Corporation (WEED) is divesting its subsidiary business, C³ Cannabinoid Compound Company GmbH, to Dermapharm Holding SE.